Oncology Molecular Diagnostics Market Review 2018-2023 and Forecast 2024-2030: 13.2% CAGR Projected, Driven by the Increasing Demand for Rapid and Accurate Diagnosis


Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Oncology Molecular Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.

The global oncology molecular diagnostic market is expected to reach an estimated $7.3 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The study includes a forecast for the global oncology molecular diagnostic by product type, type, technology, end use, and region.

The future of the global oncology molecular diagnostic market looks promising with opportunities in the hospital and diagnostic center, reference laboratory, pharmaceutical and biotechnology, and academic & research institute markets. The major drivers for this market are augmenting incidence of different cancer related cases, increasing demand for rapid and accurate diagnosis, and growing number of blood donation campaigns.

Oncology Molecular Diagnostic Market Insights

  • The report forecasts that breast is expected to witness highest growth over the forecast period due to increasing awareness of breast cancer and women's health and rising demand for minimally invasive and accurate diagnostic tests.
  • Within this market, hospital and diagnostic center is expected to witness highest growth over the forecast period due to the extensive use of molecular diagnostic tests in this field by medical professionals.
  • North America is expected to witness highest growth over the forecast period due to rising prevalence of cancer among population, existence of favorable reimbursement for health, and presence of key players in the region.

List of Oncology Molecular Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oncology molecular diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oncology molecular diagnostic companies profiled in this report include-

  • Abbott
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche
  • Cepheid
  • Bayer
  • Agilent Technologies
  • Danaher
  • Hologic
  • Sysmex

Features of the Report

  • Market Size Estimates: Oncology molecular diagnostic market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Oncology molecular diagnostic market size by various segments, such as by product type, type, technology, end use, and region in terms of ($B).
  • Regional Analysis: Oncology molecular diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product types, types, technologies, end uses, and regions for the oncology molecular diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oncology molecular diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

Key Topics Covered

1. Executive Summary

2. Global Oncology Molecular Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Oncology Molecular Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Oncology Molecular Diagnostic Market by Product Type
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Others
3.4: Global Oncology Molecular Diagnostic Market by Type
3.4.1: Blood Cancer
3.4.2: Breast Cancer
3.4.3: Prostate Cancer
3.4.4: Colorectal Cancer
3.4.5: Liver Cancer
3.4.6: Lung Cancer
3.4.7: Skin Cancer
3.4.8: Cervical Cancer
3.4.9: Others
3.5: Global Oncology Molecular Diagnostic Market by Technology
3.5.1: Polymerase Chain Reaction (PCR)
3.5.2: In-situ Hybridization (ISH)
3.5.3: Isothermic Nucleic Acid Amplification Technology (INNAT)
3.5.4: Chips & Microarrays
3.5.5: Sequencing
3.5.6: Mass Spectroscopy
3.5.7: Transcription Mediated Amplification (TMA)
3.5.8: Others
3.6: Global Oncology Molecular Diagnostic Market by End Use
3.6.1: Hospitals and Diagnostic Centers
3.6.2: Reference Laboratories
3.6.3: Pharmaceutical and Biotechnology
3.6.4: Academic & Research Institutes
3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Oncology Molecular Diagnostic Market by Region
4.2: North American Oncology Molecular Diagnostic Market
4.3: European Oncology Molecular Diagnostic Market
4.4: APAC Oncology Molecular Diagnostic Market
4.5: RoW Oncology Molecular Diagnostic Market

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Product Type
6.1.2: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Type
6.1.3: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Technology
6.1.4: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by End Use
6.1.5: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Region
6.2: Emerging Trends in the Global Oncology Molecular Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Oncology Molecular Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oncology Molecular Diagnostic Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

For more information about this report visit https://www.researchandmarkets.com/r/vs2v8u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data